-The Hindu In the eye of the storm for funding corporate warehousing projects on terms far softer than those offered to poor farmers, the National Bank for Agriculture and Rural Development (NABARD) is now blaming the Ministry of Finance (MoF) and the Reserve Bank of India (RBI) for the transgressions. Following a story in The Hindu, (‘As farmers suffer, NABARD offers soft loans to corporates, ' December 10, 2012), NABARD came under...

-PTI Pingali has been appointed director of the Tata-Cornell Initiative in Agriculture and Nutrition Washington: Former World Bank economist Prabhu Pingali has been appointed by the Cornell University to lead effort to help reduce poverty and malnutrition in India, a project established through a USD 25 million endowment from the Tata Trusts. Pingali has been appointed director of the Tata-Cornell Initiative in Agriculture and Nutrition (TACO-AN), a long-term project established through a...

-The Indian Express Law on land acquisition will reduce distortions in the use of a scarce resource Land records are in a mess in most states. While satellite imagery can yield an authentic image of the plots, it cannot determine ownership. The land acquisition issue is nearing the end of its first phase. With the government accepting key BJP demands, a consensus has been evolved and the Land Acquisition, Rehabilitation and Resettlement Bill...

-Economic and Political Weekly The Saradha group's collapse has possibly bankrupted lakhs of small investors robbing them of their life svaings, and has rendered thousands of its agents jobless. The scam highlights the failure of the government and its regulatory agencies to reign in the mushrooming chit fund companies in West Bengal. It also brings under the scanner the Trinamool Congress' proximity with the tainted group. In the wake of the...

-The Hindu Business Line From maker of versions of drugs, India's pharmaceutical industry has turned a top innovator Twenty years ago, Ranbaxy was a home-spun drug-maker. The Indian Patents Act allowed companies to make chemically-similar versions of innovative drugs. Visionaries in the pharmaceutical sector, like Parvinder Singh (Ranbaxy's key architect and member of its promoter family) and Anji Reddy (founder of Dr Reddy's Laboratories), were alive. And the pharmaceutical industry did not have...